Apostrophe raises $6 million to let you see a dermatologist from your phone

INSUBCONTINENT EXCLUSIVE:
Ben Holber and Ryan Hambley grew up together
Hambley, the son of a dermatologist, always had clear skin
But Holber struggled with acne from the time he was a teenager
The two saw first-hand the difference it makes to have a dermatologist on demand
Apostrophe was born.Apostrophe, a new startup that makes it easier to get Rx acne medications and treatments, has today announced the close
of a $6 million seed round led by SignalFire, with participation from FJ Labs.Apostrophe connects users with board-certified
dermatologists, who then develop a personalized Rx treatment plan for those patients
Apostrophe has a vertically integrated mail-order pharmacy, which facilitates the distribution of those treatment plans.The goal is to
eliminate the hassle of trips to the dermatologist, long waits in the waiting room and the general displeasure of visiting a
pharmacy.Apostrophe contracts with a physicians group to provide the dermatologists to patients, but has no direct employment relationship
with the doctors themselves
photos and fill out a questionnaire
The Apostrophe platform does some assistive organization and facilitates communication, but the tech is not involved in any diagnostic
analysis
Holber said that the decision to stay away from incorporating machine learning in the diagnostic process was a difficult but important
Apostrophe is laser-focused on the connection between dermatologists and patients through asynchronous text conversations, rather than using
noting that it takes just a few seconds for a good dermatologist to assess the issue and develop a treatment plan.Customers pay $20 for the
original consultation, and that $20 is then applied as a credit toward purchase of the suggested Rx treatment plan, which is personalized by
Apostrophe
The company makes its money off of its pharmaceutical business.Apostrophe has raised a total of $6.5 million since launch.